{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-099777","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.872101+00:00","generated_at":"2026-06-29T22:27:01.379819+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Two directors resign from EyeGate board effective August 3, 2021","bullets":["I. Keith Maher, MD and Steven Boyd resigned from the Board on August 3, 2021, effective immediately.","Resignations were not due to any disagreements with the Company's operations, policies, or practices.","No replacements were announced on the filing date."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-099777","json":"https://secwatch.observer/filing/0001104659-21-099777.json","markdown":"https://secwatch.observer/filing/0001104659-21-099777.md","text":"https://secwatch.observer/filing/0001104659-21-099777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921099777/0001104659-21-099777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921099777/tm2124037-1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:27:01.379819+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01bdff43d3","claim":"Steven Boyd resigned as Director at KIORA PHARMACEUTICALS INC.","evidence_excerpt":"On August 3, 2021, I. Keith Maher, MD and Steven Boyd resigned from the Board of Directors (the “Board”) of EyeGate Pharmaceuticals, Inc. (the “Company”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921099777/0001104659-21-099777-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ab78b53766","claim":"I. Keith Maher, MD resigned as Director at KIORA PHARMACEUTICALS INC.","evidence_excerpt":"On August 3, 2021, I. Keith Maher, MD and Steven Boyd resigned from the Board of Directors (the “Board”) of EyeGate Pharmaceuticals, Inc. (the “Company”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921099777/0001104659-21-099777-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}